Marijuana derivatives may provide MS treatment

Marijuana derivatives or “cannabinoids” taken for one year for the treatment of multiple sclerosis (MS) may reduce muscle spasms and other aspects of disability, results of a UK study suggest.

Dr. J. P. Zajicek, from Peninsula Medical School in Plymouth and colleagues previously reported that cannabinoids taken for 14 weeks appeared to improve mobility and patients’ perception of their MS symptoms. In an extension study, 80 percent of subjects agreed to continue on the medication for up to 52 weeks. The results are reported in the Journal of Neurology, Neurosurgery and Psychiatry.

The analysis included more than 500 patients who were randomly assigned to receive various cannabinoids or an inactive “placebo.”

Treatment with delta-9-THC, a synthetic cannabinoid, seemed to relieve muscle spasms. In addition, patients treated with this drug and other cannabinoids reported improvements in sleep and pain.

Zajicek’s group concludes that “there is now an urgent need to construct a long-term study in progressive MS to establish whether delta-9-THC has a role in long-term disease.”

Dr. J. Killestein and Dr. B. M. J. Uitdehaag, writing in a related editorial, agree with Zajicek’s team about the need for more long-term trials.

The editorialists, from VU Medical Centre in Amsterdam, the Netherlands, add that “these trials should also focus on different cannabinoid products.”

SOURCE: Journal of Neurology, Neurosurgery and Psychiatry, December 2005.

RELATED STORIES:
More evidence ties marijuana to stroke risk   Vitamin E may stave off Lou Gehrig’s disease   Jefferson researchers find stem cells in degenerating spinal discs, potential for repair   Researchers Get Closer to Preventing Alzheimer’s Disease   Chronic fatigue differs from depression   Dizziness Causes Don’t Differ Across Age Groups   Re-opening of carotid arteries in stroke has high success rate with stenting   To Prevent Death Or Disability Seek Immediate Care When Stroke Symptoms Occur   Researchers Publish Comparison of MS Treatments   Ancient virus protein linked to multiple sclerosis   Scientists peer into circuitry of live animal brain   Preimplantation genetic diagnosis may pose neurological risks

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]